Stéphane is co-founder and CEO of GamaMabs Pharma.
He is a confirmed biotech entrepreneur with 20 years’ experience in Biotech/Pharma and Strategy. Graduated from ESCP Europe (majoring in Finance), he started his career at Sanofi in Finance and was consultant in strategy at OC&C Consulting firm. From 2003 to 2012, he was co-founder and CFO of a biotechnology company in cancer and thrombosis, Endotis Pharma.
Under his leadership, Endotis and GamaMabs raised a total of €60 million from international funds and built a portfolio of innovative products developed up to Phase II.
Stéphane led major in-licensing / acquisition / collaboration deals for candidate drugs ranging from research to clinical stage, either with academic groups or international Pharmaceutical groups.